Sean Whooley

Pharmaceutical ingredient manufacturer Antheia announced today that it raised $56 million in Series C financing. The Menlo Park, California-based company aims to deliver ingredients to transform essential medicine supply chains. It plans to use the financing to expand the commercialization of its first product, Thebaine. The company also plans to launch additional products from its…

Roche and its Genentech unit today announced plans to invest more than $700 million in a new manufacturing facility in the U.S. The company plans to build a new 700,000 square-foot, state-of-the-art drug manufacturing plant in Holly Springs, North Carolina. It expects to add more than 400 high-wage manufacturing jobs once operational, plus more than…

ICU Medical and Otsuka Pharmaceutical Factory (OPF) announced the formation of a new joint venture to strengthen supply chain resiliency. In this joint venture, the companies say they formed Otsuka ICU Medical LLC. It aims to strengthen IV solutions supply chains and drive innovation in the North American market. The need for a more resilient…

Amgen announced that it plans to invest $900 million to expand its pharmaceutical manufacturing facility in Ohio. The expansion brings the total number of jobs created to 750. Amgen’s total investment in central Ohio now eclipses $1.4 billion. “Amgen has been a leading U.S.-based manufacturer of biologic medicines since 1988. Today’s investment reinforces our ongoing…

Roche announced plans to invest $50 billion in the U.S. over the next five years to boost manufacturing and R&D. Basel, Switzerland-based Roche says the investments strengthen its U.S. footprint and should create more than 12,000 new jobs. That includes nearly 6,500 construction jobs, plus 1,000 jobs at new and expanded facilities. As part of…

Thermo Fisher Scientific announced today that it plans to invest an additional $2 billion in the U.S. over the next four years. The company said its investment should strengthen American innovation, manufacturing and economic competitiveness in the life sciences sector. It also comes as a number of companies consider investing in U.S. infrastructure amid potential…

Bayer announced today that it opened a 70,000-square-foot expansion at its Myerstown, Pennsylvania, facility. The grand opening of the state-of-the-art facility follows a $44 million investment in 2022. Bayer says it reflects its commitment to providing self-care solutions to consumers across North America while advancing meaningful engagement with the local community. This facility in Myerstown…

Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment aims to ensure all key Novartis medicines for U.S. patients will be made in the U.S. Its financial commitment enables the company to expand on its current pharmaceutical manufacturing, research and technology…

BDD announced today that it opened a new 122-square-meter GMP manufacturing facility at BioCity near Glasgow. The company opened its facility after two years of development following a successful inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) last month. A £2 million funding round from existing investors facilitated the development of the state-of-the-art…

Ashland announced that it completed a $10 million expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil. The company plans to mark the occasion with a ribbon-cutting ceremony tomorrow, April 4. This investment significantly expands Ashland’s pharmaceutical footprint in the region and capabilities to meet increasing market demand for coated tablets in Latin America and…